Glazer Capital »

Tribeca Strategic Acquisition shares owned by Glazer Capital

Quarter-by-quarter ownership of Tribeca Strategic Acquisition shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Tribeca Strategic Acquisition

Tip: Access up to 7 years of quarterly data

All positions including Tribeca Strategic Acquisition held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tribeca Strategic Acquisition by Glazer Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.5M 550k 9.95

More positions owned by Glazer Capital

Topbuild Put Option
Penumbra Put Option (PEN)
Janus Henderson Group Ord Shs
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Select Medical Holdings Corporation
Catalyst Pharmaceutical Partners (CPRX)
HudBay Minerals (HBM)
Digitalbridge Group Cl A New (DBRG)
Chart Industries (GTLS)
Caesars Entertainment (CZR)
Esperion Therapeutics (ESPR)
Webster Financial Corporation (WBS)
Sila Realty Trust Common Stock
Cyberark Software Note 0% 06/15/2030 (Principal)

View all positions for Glazer Capital

Top funds holding Tribeca Strategic Acquisition

Magnetar Financial
Linden Advisors
LMR Partners
CNH Partners
Sona Asset Management
Bnp Paribas Arbitrage, Snc
Glazer Capital
Rivernorth Capital Management
Hudson Bay Capital Management
Polar Securities
Wealthspring Capital
Whitebox Advisors
Picton Mahoney Asset Management
Jpmorgan Chase & Co
Toronto-Dominion Bank

View all funds holding Tribeca Strategic Acquisition